Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ramnik Xavier currently holds 22,195 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ramnik Xavier has been a net neutral trader of MLTX stock. They have purchased $0 and sold $0 worth of shares.
Ramnik Xavier's most recent insider trade was on Jun 17, 2026, when they sold 22,195 shares at $0.00 per share.
Ramnik Xavier serves as Executive at MoonLake Immunotherapeutics (MLTX). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Ramnik Xavier holds the position of Executive at MoonLake Immunotherapeutics, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Ramnik Xavier has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Ramnik Xavier was on Jun 17, 2026, when they purchased $0 worth of MLTX shares. This transaction involved 22,195 shares at N/A per share.
Ramnik Xavier currently owns 22,195 shares of MoonLake Immunotherapeutics (MLTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ramnik Xavier's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ramnik Xavier has 2 Form 4 filings on record as an insider at MoonLake Immunotherapeutics.
Set alerts for Ramnik Xavier and 40,000+ other insiders.